# REGADENOSON
> **ANDA213236** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-04-11
## Drug
- **FDA Application Number:** ANDA213236
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** REGADENOSON
- **Generic name:** Regadenoson
- **Active ingredients:** REGADENOSON
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ACCORD HLTHCARE
- **First approval:** 2022-04-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213236)
---
*MORVS · CC0 1.0*